Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats

Therapeutic Advances in Gastroenterology

Volumn 3, Issue 5, 2010, Pages 281-289

  Aroch, Ilan ^a   Kazanov, Dina ^b   Hallak, Aharon ^b   Dotan, Iris ^a   Shpitz, Baruch ^a   Arber, Nadir ^b   Giladi, Nis ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

5 aminosalicylic acid; Aberrant crypt foci; Chemoprevention; Colorectal cancer; Coltect

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ANTINEOPLASTIC AGENT; COLTECT; MESALAZINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CHEMOPROPHYLAXIS; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; IN VITRO STUDY; IN VIVO STUDY; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 77956237918     PISSN: 1756283X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756283X10379258     Document Type: Article

References (37)

1. Agarwal, B., Rao, C.V., Bhendwal, S., Ramey, W.R., Shirin, H., Reddy, B.S. et al. (1999) Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology 117: 838-847.
2. Allgayer, H. and Kruis, W. ( 2002) Aminosalicylates: Potential antineoplastic actions in colon cancer prevention. Scand J Gastroenterol 37: 125-131.
3. Amantana, A., Santana-Rios, G., Butler, J.A., Xu, M., Whanger, P.D. and Dashwood, R.H. ( 2002) Antimutagenic activity of selenium-enriched green tea toward the heterocyclic amine 2-amino-3-methylimidazo[4,5-f] quinoline. Biol Trace Elem Res 86: 177-191.
4. Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A.B. and Aggarwal, B.B. ( 2008) Curcumin and cancer: An ‘old-age’ disease with an ‘age-old’ solution. Cancer Lett 267: 133-164.
5. August, D.A., Landau, J., Caputo, D., Hong, J., Lee, M.J. and Yang, C.S. ( 1999) Ingestion of green tea rapidly decreases prostaglandin E 2 levels in rectal mucosa in humans. Cancer Epidemiol Biomarkers Prev 8: 709-713.
6. Bird, R.P. ( 1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett 37: 147-151.
7. Bjarnason, I. and Macpherson, A.J. ( 1993) Delivery, safety and efficacy of 5-aminosalicylate preparations. Inflammopharmacology 2: 277-287.
8. Chen, C., Shen, G., Hebbar, V., Hu, R., Owuor, E.D. and Kong, A.N. ( 2003) Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis 24: 1369-1378.
9. Dashwood, R.H., Xu, M., Hernaez, J.F., Hasaniya, N., Youn, K. and Razzuk, A. ( 1999) Cancer chemopreventive mechanisms of tea against heterocyclic amine mutagens from cooked meat. Proc Soc Exp Biol Med 220: 239-243.
10. Finley, J.W. and Davis, C.D. ( 2001) Selenium (Se) from high-selenium broccoli is utilized differently than selenite, selenate and selenomethionine, but is more effective in inhibiting colon carcinogenesis. Biofactors 14: 191-196.
11. Gafner, S., Lee, S.K., Cuendet, M., Barthélémy, S., Vergnes, L., Labidalle, S. et al. (2004) Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems. Phytochemistry 65: 2849-2859.
12. Goel, A., Boland, C.R. and Chauhan, D.P. ( 2001) Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 72: 111-118.
13. Goel, A., Kunnumakkara, A.B. and Aggarwal, B.B. ( 2008) Curcumin as ‘Curecumin’: From kitchen to clinic. Biochem Pharmacol 75: 787-809.
14. Greenwald, P. and Kelloff, G.J. ( 1996) The role of chemoprevention in cancer control. IARC Sci Publ 139: 13-22.
15. Half, E.E. and Arber, N. (2009) Colon cancer: Preventive agents and the present status of chemoprevention. Expert Opin Pharmacother 10: 211-219.
16. Hanai, H., Iida, T., Takeuchi, K., Watanabe, F., Maruyama, Y., Andoh, A. et al. (2006) Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 24: 1502-1506.
17. Hu, Y., McIntosh, G.H., Le Leu, R.K., Woodman, R. and Young, G.P. ( 2008) Suppression of colorectal oncogenesis by selenium-enriched milk proteins: Apoptosis and K-ras mutations. Cancer Res 68: 4936-4944.
18. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. and Thun, M.J. ( 2009) Cancer statistics. CA Cancer J Clin 59: 225-249.
19. Jariwalla, R.J., Gangapurkar, B. and Nakamura, D. ( 2008) Differential sensitivity of various human tumor-derived cell types to apoptosis by organic derivatives of selenium. Br J Nutr 13: 1-8.
20. Lev-Ari, S., Strier, L., Kazanov, D., Madar-Shapiro, L., Dvory-Sobol, H., Pinchuk, I. et al. (2005 a) Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res 11: 6738-6744.
21. Lev-Ari, S., Zinger, H., Kazanov, D., Yona, D., Ben-Yosef, R., Starr, A. et al. (2005 b) Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells. Biomed Pharmacother 59(Suppl 2): S276-S280.
22. MacGregor, D.J., Kim, Y.S., Sleisenger, M.H. and Johnson, L.K. ( 2000) Chemoprevention of colon cancer carcinogenesis by balsalazide: Inhibition of azoxymethane-induced aberrant crypt formation in the rat colon and intestinal tumor formation in the B6-Min/+ mouse. Int J Oncol 17: 173-179.
23. McLellan, E. and Bird, R.P. ( 1991) Effect of disulfiram on 1,2-dimethylhydrazine and azoxymethane-induced aberrant crypt foci. Carcinogenesis 12: 969-972.
24. Moody, G.A., Jayanthi, V., Probert, C.S., Mac Kay, H. and Mayberry, J.F. ( 1996) Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: A retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 8: 1179-1183.
25. Pereira, M.A., Tao, L., Wang, W., Li, Y., Umar, A., Steele, V.E. et al. (2004) Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-alpha gene in rat colon tumors. Carcinogenesis 25: 1917-1923.
26. Roy, M., Chakrabarty, S., Sinha, D., Bhattacharya, R.K. and Siddiqi, M. ( 2003) Anticlastogenic, antigenotoxic and apoptotic activity of epigallocatechin gallate: A green tea polyphenol. Mutat Res 523-524: 33-41.
27. Sharma, R.A., Gescher, A.J. and Steward, W.P. ( 2005) Curcumin: The story so far. Eur J Cancer 41: 1955-1968.
28. Shpitz, B., Giladi, N., Sagiv, E., Lev-Ari, S., Liberman, E., Kazanov, D. et al. (2006) Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model. Digestion 74: 140-144.
29. Singh, S. and Khar, A. ( 2006) Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem 6: 259-270.
30. Stolfi, C., Fina, D., Caruso, R., Caprioli, F., Sarra, M., Fantini, M.C. et al. (2008) Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid. Biochem Pharmacol 75: 668-676.
31. Torrance, C.J., Jackson, P.E., Montgomery, E., Kinzler, K.W., Vogelstein, B., Wissner, A. et al. (2000) Combinatorial chemoprevention of intestinal neoplasia. Nat Med 6: 1024-1028.
32. Villegas, I., Sánchez-Fidalgo, S. and Alarcón de la Lastra, C. (2008) New mechanisms and therapeutic potential of curcumin for colorectal cancer. Mol Nutr Food Res 52: 1040-1061.
33. Volate, S.R., Davenport, D.M., Muga, S.J. and Wargovich, M.J. ( 2005) Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 26: 1450-1456.
34. Xiao, H., Hao, X., Simi, B., Ju, J., Jiang, H., Reddy, B.S. et al. (2008) Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F 344 rats. Carcinogenesis 29: 113-119.
35. Xu, M., Bailey, A.C., Hernaez, J.F., Taoka, C.R., Schut, H.A. and Dashwood, R.H. ( 1996) Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo [4,5-f] quinoline-induced DNA adducts and colonic aberrant crypts in the F 344 rat. Carcinogenesis 7: 1429-1434.
36. Xu, G., Ren, G., Xu, X., Yuan, H., Wang, Z., Kang, L. et al. (2010) Combination of curcumin and green tea catechins prevents dimethylhydrazine-induced colon carcinogenesis. Food Chem Toxicol 48: 390-395.
37. Yang, C.S. and Wang, Z.Y. ( 1993) Tea and cancer. J Natl Cancer Inst 85: 1038-1049.